The incretin hormones: from scientific discovery to practical therapeutics.
about
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and futureDigestive physiology of the pig symposium: gut chemosensing and the regulation of nutrient absorption and energy supplyIntestinal organoids for assessing nutrient transport, sensing and incretin secretionSitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoformsMechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study.Novel therapies for the management of type 2 diabetes mellitus: Part 2. Addressing the incretin defect in the clinical setting in 2013.Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes.Industrial natural product chemistry for drug discovery and development.Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway.No Association of Proton Pump Inhibitor Use with Fasting or Postload Glycaemia in Patients with Cardiovascular Disease: A Cross-Sectional Retrospective Study.A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes.Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinic
P2860
Q26752699-D703A6C3-9721-4B8A-B11B-FB4A9214B2A4Q27027642-29BCE9E9-4745-4095-9310-95FB602D9A52Q27305673-77A2592B-DD0D-4503-A1A7-80704E9AAC8AQ28535415-E298FB30-CA7C-4713-93A8-77F1B4808658Q37106470-BA88C397-899F-4B67-81FB-A5DCCE6B600CQ38089327-7BB68EFF-25F2-410F-BEC7-493EF156CF5BQ38113092-AE578D56-63B1-402A-9F27-E8CE17AE77C5Q38154186-52ED5A9D-4B30-45F3-A328-7C1F1DCCCC26Q39101720-50275D0F-7486-4C48-BA6D-F27BB9FCCAFBQ41035418-68A3588E-F919-4636-8E12-292D42E6E7A4Q43499161-49425EE8-1330-4592-8BB5-D8055C47AF0FQ51055379-730A8DDC-8400-4298-911C-57C968C3FEBE
P2860
The incretin hormones: from scientific discovery to practical therapeutics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The incretin hormones: from scientific discovery to practical therapeutics.
@en
The incretin hormones: from scientific discovery to practical therapeutics.
@nl
type
label
The incretin hormones: from scientific discovery to practical therapeutics.
@en
The incretin hormones: from scientific discovery to practical therapeutics.
@nl
prefLabel
The incretin hormones: from scientific discovery to practical therapeutics.
@en
The incretin hormones: from scientific discovery to practical therapeutics.
@nl
P2860
P1433
P1476
The incretin hormones: from scientific discovery to practical therapeutics.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00125-012-2561-X
P577
2012-05-04T00:00:00Z